The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival in COMBI-d, a randomized, double-blinded, phase III study comparing the combination of dabrafenib and trametinib with dabrafenib and placebo as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma.
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Helen Gogas
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Evgeny Levchenko
No Relationships to Disclose
 
Filippo G. De Braud
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
 
Thomas Jouary
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Consulting or Advisory Role - GlaxoSmithKline; MSD; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche Pharma AG
 
Jean Jacques Grob
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
 
Celeste Lebbe
Honoraria - Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis
Travel, Accommodations, Expenses - Roche
 
Mario Mandalà
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Michael Millward
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - Roche Pharma AG
 
Douglas James DeMarini
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Jhangir G Irani
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Fan Jin
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
Other Relationship - GlaxoSmithKline
 
R. Suzanne Swann
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Bijoyesh Mookerjee
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Incyte
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo
Consulting or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Lilly; Merck; Momenta Pharmaceuticals; Novartis; Oncoceutics; Sanofi; Viralytics; ZIOPHARM Oncology
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi